litlas
ログインアカウント作成

Steven Wrighton

1984–2011 年に発表

86
論文数
18,813
被引用数
77
h 指数
86
i10 指数

被引用数

Steven Wrighton の年別被引用数1983 年: 被引用 3 件1984 年: 被引用 2 件1985 年: 被引用 4 件1986 年: 被引用 25 件1987 年: 被引用 29 件1988 年: 被引用 29 件1989 年: 被引用 59 件1990 年: 被引用 86 件1991 年: 被引用 46 件1992 年: 被引用 81 件1993 年: 被引用 84 件1994 年: 被引用 79 件1995 年: 被引用 126 件1996 年: 被引用 122 件1997 年: 被引用 204 件1998 年: 被引用 192 件1999 年: 被引用 193 件2000 年: 被引用 201 件2001 年: 被引用 224 件2002 年: 被引用 322 件2003 年: 被引用 317 件2004 年: 被引用 340 件2005 年: 被引用 362 件2006 年: 被引用 322 件2007 年: 被引用 229 件2008 年: 被引用 220 件2009 年: 被引用 182 件2010 年: 被引用 150 件2011 年: 被引用 140 件2012 年: 被引用 152 件2013 年: 被引用 126 件2014 年: 被引用 112 件2015 年: 被引用 109 件2016 年: 被引用 78 件2017 年: 被引用 53 件2018 年: 被引用 45 件2019 年: 被引用 189 件2020 年: 被引用 185 件2021 年: 被引用 203 件2022 年: 被引用 101 件2023 年: 被引用 69 件2024 年: 被引用 120 件2025 年: 被引用 38 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,856 件、この内訳の 36.2%イギリス: 引用元論文 407 件、この内訳の 7.9%ドイツ: 引用元論文 277 件、この内訳の 5.4%日本: 引用元論文 271 件、この内訳の 5.3%中国: 引用元論文 250 件、この内訳の 4.9%フランス: 引用元論文 183 件、この内訳の 3.6%カナダ: 引用元論文 177 件、この内訳の 3.4%スウェーデン: 引用元論文 170 件、この内訳の 3.3%オランダ: 引用元論文 154 件、この内訳の 3%イタリア: 引用元論文 122 件、この内訳の 2.4%オーストラリア: 引用元論文 116 件、この内訳の 2.3%スイス: 引用元論文 112 件、この内訳の 2.2%
0%36.2%その他 20.1%

機関

分野

  • Pharmacology, Toxicology and Pharmaceutics44.1%
  • Medicine34.7%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Computer Science7.1%
  • Chemistry1.3%
  • Environmental Science1.2%
  • その他2.7%

トピック

  • Pharmacogenetics and Drug Metabolism19.8%
  • Drug Transport and Resistance Mechanisms10.5%
  • Computational Drug Discovery Methods6.1%
  • Pharmacological Effects and Toxicity Studies3.4%
  • Drug-Induced Hepatotoxicity and Protection2.9%
  • Analytical Chemistry and Chromatography2.2%
  • その他55.1%

共著者

全論文

検索で開く
  1. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

    著者: Peter Kuehl, Jiong Zhang, Yvonne Lin, Jatinder K. Lamba, Mahfoud Assem, John D. Schuetz, Paul B. Watkins, Ann K. Daly, Steven Wrighton, Stephen D. Hall, P Maurel, Mary V. Relling, Cynthia Brimer, Kazuto Yasuda, Raman Venkataramanan, Stephen C. Strom, Kenneth E. Thummel, Mark S. Boguski, Erin G. Schuetz - Nature Genetics 2001 被引用: 2,161

  2. Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

    著者: Daqing Wang, Yingying Guo, Steven Wrighton, George Cooke, Wolfgang Sadée - The Pharmacogenomics Journal 2010 被引用: 507

  3. THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

    著者: Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence L. Gan, Scott Grimm, John Y. Kao, Shang‐Ying P. King, Gerald T. Miwa, Lan Ni, Gondi Kumar, James F. McLeod, R. Scott Obach, Stanley Roberts, Amy L. Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, José M. Vega, John Walsh, Steven Wrighton - Drug Metabolism and Disposition 2003 被引用: 784

  4. Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7

    著者: J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, David R. Jones, James A. Eckstein, Kenneth J. Ruterbories, Mitchell A. Hamman, Stephen D. Hall, Steven Wrighton - Drug Metabolism and Disposition 2002 被引用: 468

  5. Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression

    著者: Vishal Lamba, Jatinder K. Lamba, Kazuto Yasuda, Stephen C. Strom, Julio Dávila, Michael L. Hancock, James D. Fackenthal, Peter K. Rogan, Barbara J. Ring, Steven Wrighton, Erin G. Schuetz - Journal of Pharmacology and Experimental Therapeutics 2003 被引用: 400

  6. Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans

    著者: Nagy A. Farid, Atsushi Kurihara, Steven Wrighton - The Journal of Clinical Pharmacology 2009 被引用: 391

  7. Present and future in vitro approaches for drug metabolism

    著者: Sean Ekins, Barbara J. Ring, James E. Grace, Donna J. McRobie-Belle, Steven Wrighton - Journal of Pharmacological and Toxicological Methods 2000 被引用: 227

  8. The Human Hepatic Cytochromes P450 Involved in Drug Metabolism

    著者: Steven Wrighton, Jeffrey Stevens - Critical Reviews in Toxicology 1992 被引用: 947

  9. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

    著者: Paul B. Watkins, Steven Wrighton, Erin G. Schuetz, David T. Molowa, Philip S. Guzelian - Journal of Clinical Investigation 1987 被引用: 483

  10. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

    著者: Paul B. Watkins, Scott A Murray, L G Winkelman, Douglas M. Heuman, Steven Wrighton, Philip S. Guzelian - Journal of Clinical Investigation 1989 被引用: 351

  11. In Vitro Glucuronidation Using Human Liver Microsomes and The Pore-Forming Peptide Alamethicin

    著者: Michael B. Fisher, Kristina Campanale, Bradley L. Ackermann, Mark VandenBranden, Steven Wrighton - Drug Metabolism and Disposition 2000 被引用: 342

  12. The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

    著者: Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence L. Gan, Scott Grimm, John Y. Kao, Shang‐Ying P. King, Gerald T. Miwa, Lan Ni, Gondi Kumar, James F. McLeod, Scott R. Obach, Stanley Roberts, Amy L. Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, José M. Vega, John Walsh, Steven Wrighton - The Journal of Clinical Pharmacology 2003 被引用: 309

  13. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

    著者: Paul B. Watkins, Steven Wrighton, Jeffrey L. Barnett, Kenneth S. Lown, Kent L. Kunze, Kenneth E. Thummel, Joseph C. Kolars - Drug Metabolism and Disposition 1994 被引用: 305

  14. Progress in predicting human ADME parameters in silico

    著者: Sean Ekins, Chris L. Waller, Peter W. Swaan, Gabriele Cruciani, Steven Wrighton, James H. Wikel - Journal of Pharmacological and Toxicological Methods 2000 被引用: 277

  15. Molecular and physical mechanisms of first-pass extraction.

    著者: Stephen D. Hall, Kenneth E. Thummel, Paul B. Watkins, Kenneth S. Lown, Leslie Z. Benet, Mary F. Paine, Robert R. Mayo, D. Kim Turgeon, David G. Bailey, Robert J. Fontana, Steven Wrighton - 1999 被引用: 239

  16. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide

    著者: John R. Cashman, Sang B. Park, Ziping Yang, Steven Wrighton, Peyton Jacob, Neal L. Benowitz - Chemical Research in Toxicology 1992 被引用: 213

  17. THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS*

    著者: Steven Wrighton, Erin G. Schuetz, Kenneth E. Thummel, Danny D. Shen, Kenneth R. Korzekwa, Paul B. Watkins - Drug Metabolism Reviews 2000 被引用: 211

  18. The human drug metabolizing cytochromes P450

    著者: Steven Wrighton, Mark VandenBranden, Barbara J. Ring - Journal of Pharmacokinetics and Biopharmaceutics 1996 被引用: 166

  19. The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2

    著者: Eric T. Williams, Karen O. Jones, G. Douglas Ponsler, Shane M. Lowery, E.J. Perkins, Steven Wrighton, Kenneth J. Ruterbories, Miho Kazui, Nagy A. Farid - Drug Metabolism and Disposition 2008 被引用: 127

  20. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†

    著者: Michael B. Fisher, Mary F. Paine, Timothy J. Strelevitz, Steven Wrighton - Drug Metabolism Reviews 2001 被引用: 371

  21. Selectivity of the Multidrug Resistance Modulator, LY335979, for P-Glycoprotein and Effect on Cytochrome P-450 Activities

    著者: Anne H. Dantzig, Robert L. Shepard, K L Law, Linda B. Tabas, Susan E. Pratt, Jennifer S. Gillespie, S N Binkley, Michael T. Kuhfeld, James J. Starling, Steven Wrighton - Journal of Pharmacology and Experimental Therapeutics 1999 被引用: 179

  22. Differential Modulation of UDP-Glucuronosyltransferase 1A1 (UGT1A1)-Catalyzed Estradiol-3-glucuronidation by the Addition of UGT1A1 Substrates and Other Compounds to Human Liver Microsomes

    著者: J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, Kristina Campanale, David Jones, Stephen D. Hall, Steven Wrighton - Drug Metabolism and Disposition 2002 被引用: 152

  23. Effects of Antipsychotic Drugs on Ito, INa, Isus, IK1, and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis

    著者: William Crumb, Sean Ekins, R. Dustan Sarazan, James H. Wikel, Steven Wrighton, Christopher Carlson, Charles M. Beasley - Pharmaceutical Research 2006 被引用: 89

  24. Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human

    著者: Eric T. Williams, James A. Bacon, David M. Bender, Jennifer J. Lowinger, Wenkai Guo, Mariam Ehsani, Xiliang Wang, He Wang, Yuewei Qian, Kenneth J. Ruterbories, Steven Wrighton, E.J. Perkins - Drug Metabolism and Disposition 2011 被引用: 72